Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Drug Seeking Behavior in ER Doubles

Catasys Health - Thursday, October 28, 2010

Drug Seeking Behavior in ER Doubles, Feeds Growing Addiction to Pain Pills -- Emergency rooms continue to become a major resource for pain medication addicts; By MIKAELA CONLEY, ABC News Medical Unit -- Oct. 28, 2010 » More



Comments (0) | Trackbacks (0) | Permalink

Hospitalizations for Drug Use Up Dramatically

Catasys Health - Wednesday, October 27, 2010

Cheryl Clark, for HealthLeaders Media, October 27, 2010
Medication and illegal drug-related problems put twice as many middle-aged and older Americans in the hospital in 2008 as in 1997, according to a report from the Agency for Healthcare Research and Quality. » More



Comments (0) | Trackbacks (0) | Permalink

Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More



Comments (0) | Trackbacks (0) | Permalink

Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: » More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
mental illness depression SD health insurance stimulants nicotine methamphetamine dependence vivitrol behavioral health care services relapse prevention CIWA alcohol treatment pain killers Journal of Psychopharmacology high-utilizing heroin painkillers chronic pain methadone substance use disorder suboxone sugar mental health alcohol drug use pain pills Harold Urschel Raymond Anton primary care over-the-counter substances post-traumatic stress disorder reduction in use opioid antagonist smoking dependence issues PTSD drug abuse alcohol drinking physician- patient relations pain medication data mining vicodin SD members prometa randomized health reform stress addiction Research Across America sober morphine buprenorphine health plan anxiety substance dependence costs medical costs behavioral health naloxone substance dependence health insurance reducing craving binge drinking ADHD craving score cocaine treatment emergency room opioid overdose medical and behavioral costs placebo-controlled behavioral healthcare addiction treatment cigarettes behavioral health care substance dependence overdose opioid abuse fentanyl gabapentin Health Care Utilization opiod abuse muscle relaxant opioid drinking trauma communication psychosocial identification craving bipolar disorder ADD flumazenil ER reduction in craving OxyContin depression screening treatment sobriety hospital UnitedHealthcare OnTrak diabetes urine drug screen alcohol dependence facebook stratified hydrocodone drug treatment contract hospitalizations double-blind opiates percocet Opioid Treatment drug addicts narcotic care coaching placebo opiod-based meth recovery health insurance predictive modeling methamphetamine opioid-drug interactions prescriptions social network behavioral healthcare services recovery network oxycodone alcoholism Catasys Opioid Medications relapse addict marijuana withdrawal drug addiction codeine Co Occurring Disorders medical cocaine
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025